ABVC BioPharma closed a private placement of senior convertible promissory notes, raising approximately $3.39 million before fees. The notes carry a 17.5% interest rate, mature in June 2027, and convert into common stock after eight months at a discount. Proceeds will support working capital, subsidiary funding, and a $625,000 settlement payment, aiding the company's broader financing and development strategy. ABVC aims to advance its pharmaceutical and medical-device projects through licensing, subsidiary growth, and strategic financing.
ABVC BioPharma's recent private placement of convertible notes is presented here with a snapshot of the health sector on Pluang. For readers following health stocks, as of Nov 02, 2026 21:12 WIB, 104 of 150 priced US health-sector stocks rose while 33 fell. Among notable movers, MRVI traded at USD 8.03 with a 2.82% increase and a typical hold time of 14 days, ADPT was priced at USD 27.36 up 2.78% with a 37-day hold, and BNGO stood at USD 1.18 rising 2.61% with investors typically holding for 52 days.
The global bio-based construction polymer market, valued at $18.2 billion in 2025, is projected to grow to $35 billion by 2033 at an 8.3% CAGR. Growth is fueled by rising demand for sustainable building materials that reduce greenhouse gas emissions ...
Annual Over-the-Air (OTA) software updates for software-defined vehicles (SDVs) are projected to reach over 2 billion globally by 2035, up from 546 million in 2025, driven by rising SDV sales and advanced vehicle software platforms. Level 3 and above...
Fram Wind Solutions AS, a joint venture partly owned by BW Offshore, secured a NOK 1.94 billion grant from Enova to develop a floating offshore wind project featuring two 18.5 MW turbines, the largest globally, with a combined capacity of 37 MW. The ...
Thailand's textile market is projected to grow from USD 4.97 billion in 2026 to USD 5.39 billion by 2032, at a CAGR of 1.31%. Growth is fueled by domestic fiber production, machinery upgrades, and rising demand for faster garment replenishment, espec...
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
